Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? - PubMed (original) (raw)
Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
F Licastro et al. J Neuroimmunol. 2000.
Free article
Abstract
Plasma concentrations of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), C reactive protein (CRP) and alpha-1-antichymotrypsin (ACT) in 145 patients with probable Alzheimer's disease (AD) and 51 non-demented controls were measured. To investigate the cellular activation of peripheral immune system, plasma levels of neopterin were also investigated. Plasma levels of IL-1 were detectable in 17 patients with AD (13%) and only in one control (2%) and average levels of IL-1 were higher in AD patients than in controls (p < 0.001). IL-6 plasma levels were detectable in a higher proportion of AD and controls (53% and 27%, respectively), and were increased in patients with AD (p < 0.001). Plasma levels of ACT were increased in patients with AD (p < 0.001) and CRP levels were in the normal range. Plasma levels of neopterin were slightly lower in AD patients than in controls, but differences were not statistically significant. No significant correlation was observed between IL-1 and IL-6 levels or neopterin and cytokine levels in plasma from AD patients. Plasma levels of ACT negatively correlated with cognitive performances, as assessed by the mini mental state examination (MMSE; R = -0.26, p < 0.02) and positively correlated with the global deterioration state (GDS) of AD patients (R = 0.30, p < 0.007). Present findings suggested that detectable levels of circulating cytokines and increased ACT might not be derived by activation of peripheral immune system of AD patients. Detection of these molecules might be used for monitoring the progression of brain inflammation associated with AD.
Similar articles
- Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
Licastro F, Pedrini S, Ferri C, Casadei V, Govoni M, Pession A, Sciacca FL, Veglia F, Annoni G, Bonafè M, Olivieri F, Franceschi C, Grimaldi LM. Licastro F, et al. Ann Neurol. 2000 Sep;48(3):388-91. Ann Neurol. 2000. PMID: 10976648 - Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
Licastro F, Morini MC, Polazzi E, Davis LJ. Licastro F, et al. J Neuroimmunol. 1995 Mar;57(1-2):71-5. doi: 10.1016/0165-5728(94)00163-i. J Neuroimmunol. 1995. PMID: 7535791 - Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD. Lanzrein AS, et al. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):215-27. doi: 10.1097/00002093-199809000-00016. Alzheimer Dis Assoc Disord. 1998. PMID: 9772027 - Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, Carvalho AF, Herrmann N. Lai KSP, et al. J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):876-882. doi: 10.1136/jnnp-2017-316201. Epub 2017 Aug 9. J Neurol Neurosurg Psychiatry. 2017. PMID: 28794151 - Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
Frodl T, Amico F. Frodl T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:295-303. doi: 10.1016/j.pnpbp.2012.12.013. Epub 2013 Jan 11. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 23313563 Review.
Cited by
- Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.
Cortese GP, Burger C. Cortese GP, et al. Behav Brain Res. 2017 Mar 30;322(Pt B):269-279. doi: 10.1016/j.bbr.2016.08.027. Epub 2016 Aug 17. Behav Brain Res. 2017. PMID: 27544872 Free PMC article. Review. - High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease.
Bouvier DS, Jones EV, Quesseveur G, Davoli MA, A Ferreira T, Quirion R, Mechawar N, Murai KK. Bouvier DS, et al. Sci Rep. 2016 Apr 19;6:24544. doi: 10.1038/srep24544. Sci Rep. 2016. PMID: 27090093 Free PMC article. - Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.
Lepara O, Alajbegovic A, Zaciragic A, Nakas-Icindic E, Valjevac A, Lepara D, Hadzovic-Dzuvo A, Fajkic A, Kulo A, Sofic E. Lepara O, et al. J Neural Transm (Vienna). 2009 Dec;116(12):1651-6. doi: 10.1007/s00702-009-0325-7. Epub 2009 Oct 7. J Neural Transm (Vienna). 2009. PMID: 19809863 - Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
Brosseron F, Krauthausen M, Kummer M, Heneka MT. Brosseron F, et al. Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25. Mol Neurobiol. 2014. PMID: 24567119 Free PMC article. Review. - Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.
Lönneborg A. Lönneborg A. Mol Diagn Ther. 2008;12(5):307-20. doi: 10.1007/BF03256296. Mol Diagn Ther. 2008. PMID: 18803429 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous